Search results for "Infectious"

showing 10 items of 2953 documents

Inhibition by cellular vacuolar ATPase impairs human papillomavirus uncoating and infection.

2014

ABSTRACT Several viruses, including human papillomaviruses, depend on endosomal acidification for successful infection. Hence, the multisubunit enzyme vacuolar ATPase (V-ATPase), which is mainly responsible for endosome acidification in the cell, represents an attractive target for antiviral strategies. In the present study, we show that V-ATPase is required for human papillomavirus (HPV) infection and that uncoating/disassembly but not endocytosis is affected by V-ATPase inhibition. The infection inhibitory potencies of saliphenylhalamide, a proven V-ATPase inhibitor, and its derivatives, as well as those of other V-ATPase inhibitors, were analyzed on different HPV types in relevant cell l…

Vacuolar Proton-Translocating ATPasesEndosomeCell SurvivalCellBiologyAlphapapillomavirusEndocytosisInhibitory postsynaptic potentialAntiviral AgentsCell LineViral ProteinsmedicineHumansPharmacology (medical)Vacuolar ATPasePharmacologychemistry.chemical_classificationVacuolar Proton-Translocating ATPasesVirologyEndocytosisCell biologyInfectious Diseasesmedicine.anatomical_structureEnzymechemistryCell cultureHeLa CellsAntimicrobial agents and chemotherapy
researchProduct

Comparison of the performance of different HPV genotyping methods for detecting genital HPV types

2008

Classification of high-risk HPV types for cervical cancer screening depends on epidemiological studies defining HPV type-specific risk. The genotyping tests that are used, are however, not uniform with regard to type-specific detection rates making comparisons between different studies difficult. To overcome the lack of a “gold standard” four tests were evaluated crosswise using 824 cervical smears pretested by HC2. The tests evaluated were the L1-PCR-based assays PGMY09/11 LBA, HPV DNA Chip and SPF LiPA and an E1 consensus PCR followed by cycle sequencing (E1-PCR). A subset of 265 samples was tested in addition with the GP5+/6+ reverse line blot assay. Differences were noted in the sensiti…

Vaginal SmearsGenotypebusiness.industryPapillomavirus InfectionsConsensus PCRUterine Cervical NeoplasmsCervix UteriGold standard (test)Cervical intraepithelial neoplasiamedicine.diseaseSensitivity and SpecificityVirologyInfectious DiseasesVirologyGenotypeHumansMedicineFemaleSex organTypingbusinessPapillomaviridaeGenotypingKappaJournal of Medical Virology
researchProduct

Female genital schistosomiasis--a differential diagnosis to sexually transmitted disease: genital itch and vaginal discharge as indicators of genital…

2008

OBJECTIVE To examine the association between schistosomiasis and reproductive tract symptoms. METHOD A cross-sectional study was conducted in a Schistosoma haematobium-endemic area of rural Zimbabwe. A total of 483 permanently resident adult women of Mupfure Ward aged 20-49 were interviewed and examined clinically, each providing three consecutive urine samples. Logistic regression analysis was used to control for sexually transmitted diseases (STDs). RESULTS Women with genital sandy patches had significantly more genital itch (P = 0.009) and perceived their discharge as abnormal (P = 0.003). Eighty percent of the women who had genital itch, yellow discharge, and childhood or current waterb…

Vaginal dischargeSexually transmitted diseaseAdultRural PopulationZimbabwemedicine.medical_specialtyEndemic DiseasesPopulationSexually Transmitted DiseasesSchistosomiasisDiagnosis DifferentialYoung AdultVaginal diseasemedicineAnimalsHumansSchistosomiasiseducationSchistosomaLeukorrheaSchistosoma haematobiumeducation.field_of_studybiologybusiness.industryObstetricsPruritusPublic Health Environmental and Occupational HealthMiddle Agedmedicine.diseasebiology.organism_classificationInfectious DiseasesCross-Sectional StudiesVaginal DischargeImmunologyVaginaSchistosoma haematobiumParasitologyFemalemedicine.symptomMorbiditybusinessGenital Diseases FemaleTropical medicineinternational health : TMIH
researchProduct

A combined measles, mumps, rubella and varicella vaccine (Priorix-Tetra: immunogenicity and safety profile

2009

Abstract Priorix-Tetra ™ (GlaxoSmithKline Biologicals) is a combined measles, mumps, rubella and varicella (MMRV) vaccine. Eight studies involving more than 3000 children were reviewed. Compared with co-administration of MMR ( Priorix ™) and varicella ( Varilrix ™) vaccines, the MMRV vaccine showed: similar immunogenicity, with immunity shown up to 3 years post-vaccination; a higher rate of fever after the first dose; a slight increase in mild local reactions after the second dose. This MMRV vaccine can be used either as a two-dose vaccine or as a second dose in children primed with separate MMR and/or varicella vaccines, offering a convenient way to introduce varicella vaccination into rou…

Varicella vaccineImmunization Secondarymedicine.vaccineAntibodies ViralRubellaMeaslesChickenpox VaccinemedicineHumansVaccines CombinedChildClinical Trials as TopicReactogenicityMMRV vaccineGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryImmunogenicityPublic Health Environmental and Occupational HealthInfantvirus diseasesmedicine.diseaseVirologyVaccinationInfectious DiseasesImmunizationChild PreschoolMolecular MedicinebusinessMeasles-Mumps-Rubella Vaccine
researchProduct

MMR and MMRV vaccines.

2018

Measles, mumps, rubella and varicella are viral infections which can implicate seriously long-term sequelae of infected individuals or even the unborn child. Vaccines against the individual diseases have long been available. Global measles vaccination is estimated to have prevented more than 20million deaths during 2000-2015. During the same time period, measles incidence decreased from 146 to 36 cases per million populations. Today vaccinations against measles, mumps, rubella and varicella are now carried out mainly with combination vaccines. These are today known as immunogenic and safe. MMRV had similar immunogenicity and overall safety profiles to MMR administered with or without varice…

Varicella vaccineRubellaMeasles03 medical and health sciences0302 clinical medicineChickenpox030225 pediatricsmedicineHumans030212 general & internal medicineAdverse effectMumpsRubellaVaccinesGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryImmunogenicityIncidence (epidemiology)VaccinationPublic Health Environmental and Occupational Healthvirus diseasesmedicine.diseaseVaccinationInfectious DiseasesImmunizationImmunologyMolecular MedicinebusinessMeaslesVaccine
researchProduct

Characterisation of fascioliasis lymnaeid intermediate hosts from Chile by DNA sequencing, with emphasis on Lymnaea viator and Galba truncatula.

2011

In South America, Fasciola hepatica infection poses serious health problems in both humans and livestock. In Chile, the medical impact appears yearly stable and mainly concentrated in central regions, where the veterinary problem is highlighted by higher animal prevalences. Studies were undertaken by rDNA ITS-2 and ITS-1 and mtDNA cox1 sequencing to clarify the specific status of the lymnaeids, their geographical distribution and fascioliasis transmission capacity in Chile, by comparison with other American countries and continents. Results change the lymnaeid scenario known so far. The lymnaeid fauna of mainland Chile shows to be poor, including only two authochthonous species, Lymnaea via…

Veterinary (miscellaneous)FaunaMolecular Sequence DataZoologyHelminth geneticsIntroduced speciesDNA MitochondrialDNA sequencingLymnaeidaeElectron Transport Complex IVMitochondrial ProteinsIntergenic regionAcanthaceaeparasitic diseasesDNA Ribosomal SpacerHelminthsAnimalsCluster AnalysisChilePhylogenyGalba truncatulabiologyEcologySequence Analysis DNADNA HelminthFasciola hepaticabiology.organism_classificationInfectious DiseasesInsect ScienceParasitologyActa tropica
researchProduct

From the Field to the Laboratory: Quantifying Outdoor Mosquito Landing Rate to Better Evaluate Topical Repellents.

2021

Abstract Vector-borne diseases are a worldwide threat to human health. Often, no vaccines or treatments exist. Thus, personal protection products play an essential role in limiting transmission. The World Health Organization (WHO) arm-in-cage (AIC) test is the most common method for evaluating the efficacy of topical repellents, but it remains unclear whether AIC testing conditions recreate the mosquito landing rates in the field. This study aimed to estimate the landing rate outdoors, in an area of Europe highly infested with the Asian tiger mosquito (Aedes albopictus (Skuse, 1894, Diptera: Culididae)), and to determine how to replicate this rate in the laboratory. To assess the landing ra…

Veterinary medicineAedes albopictusMosquito Control030231 tropical medicineCommon methodMosquito VectorsWorld health03 medical and health sciencesHuman health0302 clinical medicineAedesparasitic diseasesAnimals030304 developmental biology0303 health sciencesGeneral VeterinarybiologyfungiReplicateFeeding Behaviorbiology.organism_classificationInfectious DiseasesItalyInsect ScienceReference valuesFlight AnimalInsect RepellentsTiger mosquitoParasitologyFemaleField conditionsJournal of medical entomology
researchProduct

The Asian Taenia and the possibility of cysticercosis

2000

In certain Asian countries, a third form of human Taenia, also known as the Asian Taenia, has been discovered. This Asian Taenia seems to be an intermediate between Taenia solium and T. saginata since in morphological terms it is similar to T. saginata, yet biologically, as it uses the same intermediate host (pigs), it is more akin to T. solium. Taenia solium causes human cysticercosis, while T. saginata does not. It is not known whether the Asian taeniid is able to develop to the larval stage in humans or not. The arguments proposed by those authors who consider it unlikely that the Asian Taenia causes human cysticercosis are: (a) its molecular similarities with T. saginata; (b) the absenc…

Veterinary medicineAsiaZoologyBiologydigestive systemparasitic diseasesTaenia soliumPrevalencemedicineAsian countryAnimalsHumansHelminthsIntestinal Diseases ParasiticCestode infectionsTaeniaCysticercosismusculoskeletal neural and ocular physiologyIntermediate hostCysticercosisMini-Reviewmusculoskeletal systemmedicine.diseasebiology.organism_classificationmedicine.drug_formulation_ingredientInfectious DiseasesLarvaTaeniaParasitologyThe Korean Journal of Parasitology
researchProduct

Phenotypic analysis of adults of Fasciola hepatica, Fasciola gigantica and intermediate forms from the endemic region of Gilan, Iran.

2006

Fascioliasis is an important human and animal disease caused by Fasciola hepatica and Fasciola gigantica. In Iran, the distribution of these two species overlaps in most areas, including the northern human endemic province of Gilan where both fasciolids are simultaneously found in individual cattle and buffaloes. A phenotypic study of fasciolid adult flukes from naturally infected bovines from Gilan was carried out by means of an exhaustive morphometric analysis using traditional microscopic measurements and an allometric model. The Iranian fasciolids were compared to F. hepatica and F. gigantica standard populations, i.e. from geographical areas where both species do not co-exist (Bolivia …

Veterinary medicineBoliviaFascioliasisTime FactorsBuffaloesEndemic DiseasesFasciola giganticaAllopatric speciationCattle DiseasesIranPhenotypic analysisSpecies SpecificityHepaticaparasitic diseasesBurkina FasoSuckerFasciola hepaticaAnimalsbiologyEcologyAnimal diseaseFasciola hepaticabiology.organism_classificationClassificationFasciolaInfectious DiseasesLogistic ModelsPhenotypeLiverParasitologyCattleAllometryParasitology international
researchProduct

Assessing the validity of an ELISA test for the serological diagnosis of human fascioliasis in different epidemiological situations

2012

Objectives To improve the diagnosis of human fascioliasis caused by Fasciola hepatica and Fasciola gigantica, we evaluated the diagnostic accuracy of an enzyme-linked immunosorbent assay (ELISA), with Fasciola antigen from the adult liver fluke, for the detection of IgG against fascioliasis in human sera. Methods The sera of 54 fascioliasis cases, originating from three endemic areas, were used in this evaluation: (i) a hyperendemic F. hepatica area where humans usually shed a great number of parasite eggs in faeces (11 sera); (ii) an epidemic F. hepatica area where humans usually shed small amounts of parasite eggs (24 sera) and (iii) an overlap area of both Fasciola species and where huma…

Veterinary medicineFasciolabiologyFasciola giganticaPublic Health Environmental and Occupational Healthbiology.organism_classificationSerologyInfectious DiseasesAntigenHepaticaparasitic diseasesFasciola hepaticaParasite hostingParasitologyFecesTropical Medicine & International Health
researchProduct